• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Onset of Philadelphia chromosome negative chronic myeloid leukemia with symptoms of intrahepatic cholestasis].

作者信息

Döbrönte Z, Bodnár M, Löcsei Z, Brittig F, Varga L, István L

出版信息

Orv Hetil. 1989 Oct 22;130(43):2315-8.

PMID:2812760
Abstract

The case of a chronic myelogenous leukemia (CML) starting in an unusual form in a young woman is reported. Rapidly progressing icterus was the first and leading symptom of the disease. Simultaneously with the exclusion of the possibility of hepatitis and extrahepatic obstruction of the bile duct the qualitative blood picture roused the suspicion of a myeloproliferative disease. Detailed hematological examinations confirmed Philadelphia chromosome (Ph1) negative CML. Besides the histologically diffuse leukemic infiltration intrahepatic cholostasis could be demonstrated in the background of the icterus. In the chronic and accelerated phase clinical symptoms developing as a consequence of hepatic organic manifestation were dominating. In the authors's case the moderate leukocytosis, initial thrombocytopenia, absence of splenomegaly, early blast-phase and short survival were atypical, characteristic of Ph1 negative CML. The diagnosis and the absence of other associated hepatopathies was supported also by the post-mortem examination. CML beginning with icteric symptoms due to intrahepatic cholostasis is considered as rarity in the literature.

摘要

相似文献

1
[Onset of Philadelphia chromosome negative chronic myeloid leukemia with symptoms of intrahepatic cholestasis].
Orv Hetil. 1989 Oct 22;130(43):2315-8.
2
Philadelphia negative, Bcr-Abl positive chronic myeloid leukemia associated with pure red cell aplasia.费城染色体阴性、Bcr-Abl阳性慢性髓性白血病伴纯红细胞再生障碍。
J Exp Clin Cancer Res. 2003 Jun;22(2):341-2.
3
Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.费城染色体阴性、bcr/abl阴性慢性粒细胞白血病患者的特征及预后
Cancer. 2002 Oct 15;95(8):1673-84. doi: 10.1002/cncr.10832.
4
Cytogenetic profile of chronic myeloid leukemias.慢性髓性白血病的细胞遗传学特征
Indian J Cancer. 2002 Jun;39(2):61-5.
5
[The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].[bcr/abl重排在慢性髓性白血病诊断及病情进展中的应用价值]
Med Clin (Barc). 1993 Oct 30;101(14):521-4.
6
Spontaneous splenic rupture in atypical (Philadelphia chromosome negative) chronic myeloid leukaemia following blastic crisis.原始细胞危象后非典型(费城染色体阴性)慢性髓性白血病的自发性脾破裂
Ir Med J. 2003 Jun;96(6):181-2.
7
[Blast crisis accompanied by severe DIC of Ph negative chronic myeloid leukemia showing t(9;16) and positive M-BCR/ABL rearrangement].伴有严重弥散性血管内凝血的Ph阴性慢性髓性白血病急变期,显示t(9;16)和M-BCR/ABL重排阳性
Rinsho Ketsueki. 1997 Aug;38(8):663-68.
8
[Chronic myeloid leukemia without Philadelphia chromosome (Ph-negative CML)].无费城染色体的慢性髓性白血病(Ph阴性慢性髓性白血病)
Acta Haematol Pol. 1993;24(3):221-5.
9
[Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].STI571治疗慢性髓性白血病患者的临床疗效及副作用
Ai Zheng. 2004 Apr;23(4):421-5.
10
[Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].[甲磺酸伊马替尼治疗费城染色体阳性慢性髓性白血病患者后异常费城染色体阴性细胞的克隆进化]
Zhonghua Xue Ye Xue Za Zhi. 2005 Jan;26(1):23-6.